Article info

Download PDFPDF
Letter
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases

Authors

  1. Correspondence to Dr Hung Shih-Chang, Nantou Hospital, Nantou, Taiwan; shihchan{at}gmail.com
View Full Text

Citation

Shih-Chang H
Advanced ALK-positive lung cancer with lorlatinib versus crizotinib in Asian patients with brain metastases

Publication history

  • First published September 14, 2021.
Online issue publication 
December 19, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.